Akihiro Murakami

2.1k total citations
55 papers, 1.6k citations indexed

About

Akihiro Murakami is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Akihiro Murakami has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Epidemiology. Recurrent topics in Akihiro Murakami's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Eosinophilic Disorders and Syndromes (9 papers) and Inflammatory Myopathies and Dermatomyositis (8 papers). Akihiro Murakami is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Eosinophilic Disorders and Syndromes (9 papers) and Inflammatory Myopathies and Dermatomyositis (8 papers). Akihiro Murakami collaborates with scholars based in Japan, Brazil and Kuwait. Akihiro Murakami's co-authors include Tsuneyo Mimori, Yoshinori Suminami, Hiroshi Kato, Fumitaka Numa, Takeshi Watanabe, Chinkichi Ogino, Takafumi Suda, Norihiro Sugino, Manabu Fujimoto and Shugo Nawata and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and British Journal of Cancer.

In The Last Decade

Akihiro Murakami

54 papers receiving 1.6k citations

Peers

Akihiro Murakami
Hua Ye China
Tauro Maria Neri Italy
J. Cooper Booth Australia
Raajit K. Rampal United States
Robert E. Emerson United States
Börje Ridell Sweden
Tatsuki R. Kataoka Japan
Angshumoy Roy United States
Aya Kawasaki Japan
Nadim Mahmud United States
Hua Ye China
Akihiro Murakami
Citations per year, relative to Akihiro Murakami Akihiro Murakami (= 1×) peers Hua Ye

Countries citing papers authored by Akihiro Murakami

Since Specialization
Citations

This map shows the geographic impact of Akihiro Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Murakami more than expected).

Fields of papers citing papers by Akihiro Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Murakami. The network helps show where Akihiro Murakami may publish in the future.

Co-authorship network of co-authors of Akihiro Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Murakami. A scholar is included among the top collaborators of Akihiro Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Murakami. Akihiro Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naiki‐Ito, Aya, Akihiro Murakami, Masayuki Komura, et al.. (2025). Hepatic stellate cell inhibition by angiotensin II receptor blocker mitigates liver injury and fibrosis via NF-κB-galectin-3 suppression in a rat nonalcoholic steatohepatitis model. Archives of Toxicology. 99(8). 3393–3412. 1 indexed citations
2.
Arai, Toru, Masaki Hirose, Tomoko Kagawa, et al.. (2022). Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis. Canadian Respiratory Journal. 2022. 1–10. 3 indexed citations
3.
Okiyama, Naoko, Yuki Ichimura, Ryota Tanaka, et al.. (2021). Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis. Annals of the Rheumatic Diseases. 80(9). 1201–1208. 31 indexed citations
4.
Hozumi, Hironao, Tomoyuki Fujisawa, Noriyuki Enomoto, et al.. (2017). Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease. The Journal of Rheumatology. 44(9). 1394–1401. 37 indexed citations
5.
Fujimoto, Manabu, Akihiro Murakami, Naoko Okiyama, et al.. (2016). Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis. Journal of Dermatological Science. 84(3). 272–281. 62 indexed citations
6.
Nakashima, Ran, Yoshitaka Imura, Yuji Hosono, et al.. (2014). The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia. PLoS ONE. 9(1). e85062–e85062. 93 indexed citations
7.
Murakami, Akihiro, et al.. (2013). Change in Water and Sediment Quality in Ohfunato Bay induced by the 2011 Great East Japan Tsunami. Journal of Japan Society of Civil Engineers Ser B2 (Coastal Engineering). 69(2). I_496–I_500. 6 indexed citations
8.
Itamochi, Hiroaki, Ryuichiro Nishimura, Fumitaka Numa, et al.. (2012). Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group. International Journal of Clinical Oncology. 18(6). 1107–1113. 25 indexed citations
9.
Shiokawa, Miho, Takeshi Takahashi, Akihiro Murakami, et al.. (2010). In vivo assay of human NK-dependent ADCC using NOD/SCID/γcnull (NOG) mice. Biochemical and Biophysical Research Communications. 399(4). 733–737. 18 indexed citations
10.
Nustad, Kjell, Ola Nilsson, Akihiro Murakami, et al.. (2009). Characterization of Monoclonal Antibodies Directed against Squamous Cell Carcinoma Antigens: Report of the Second TD-10 Workshop. Tumor Biology. 30(1). 26–36. 8 indexed citations
11.
Suzuki, Kazuo, Tetsuji Sawada, Akihiro Murakami, et al.. (2003). High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scandinavian Journal of Rheumatology. 32(4). 197–204. 135 indexed citations
12.
13.
Murakami, Akihiro, et al.. (2001). Squamous cell carcinoma antigen suppresses radiation-induced cell death. British Journal of Cancer. 84(6). 851–858. 78 indexed citations
14.
Murakami, Akihiro, Yoshinori Suminami, Shugo Nawata, et al.. (2000). Specific Detection and Quantitation of <i>SCC Antigen 1</i> and <i>SCC Antigen 2</i> mRNAs by Fluorescence-Based Asymmetric Semi-Nested Reverse Transcription PCR. Tumor Biology. 21(4). 224–234. 26 indexed citations
15.
Nawata, Shugo, Akihiro Murakami, Kei Hirabayashi, et al.. (1999). Identification of squamous cell carcinoma antigen-2 in tumor tissue by two-dimensional electrophoresis. Electrophoresis. 20(3). 614–617. 13 indexed citations
16.
Moraes, Vera Maria Barbosa de, et al.. (1997). Levadura de vinhaca (Saccharomyces cerevisae) como fonte proteica na alimentacao de frangos em crescimento e postura. 13(2). 150–156. 1 indexed citations
17.
Ariki, J, et al.. (1993). Utilizacao da farinha integral crua de graos de soja na alimentacao de frangos de corte. 21(1). 31–38. 1 indexed citations
18.
Ariki, J, et al.. (1993). Levedura de vinhaca ( saccharomyces cerevisiae ) como fonte proteica na alimentacao de frangos de corte. 22(5). 876–883. 3 indexed citations
19.
Watanabe, Takeshi, Toshio Takeuchi, Akihiro Murakami, & Chinkichi Ogino. (1980). The availability to Tilapia nilotica of phosphorus in white fish meal.. NIPPON SUISAN GAKKAISHI. 46(7). 897–899. 33 indexed citations
20.
Watanabe, Takeshi, et al.. (1980). Requirement of chum salmon held in freshwater for dietary phosphorus.. NIPPON SUISAN GAKKAISHI. 46(3). 361–367. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Ye Breakdown of academic impact, for papers by Tauro Maria Neri Breakdown of academic impact, for papers by J. Cooper Booth Breakdown of academic impact, for papers by Raajit K. Rampal Breakdown of academic impact, for papers by Robert E. Emerson Breakdown of academic impact, for papers by Börje Ridell Breakdown of academic impact, for papers by Tatsuki R. Kataoka Breakdown of academic impact, for papers by Angshumoy Roy Breakdown of academic impact, for papers by Aya Kawasaki Breakdown of academic impact, for papers by Nadim Mahmud
Rankless by CCL
2026